Greco et al., 2018 - Google Patents
Circular RNAs in muscle function and diseaseGreco et al., 2018
View HTML- Document ID
- 183076104396126980
- Author
- Greco S
- Cardinali B
- Falcone G
- Martelli F
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Circular RNAs (circRNAs) are a class of RNA produced during pre-mRNA splicing that are emerging as new members of the gene regulatory network. In addition to being spliced in a linear fashion, exons of pre-mRNAs can be circularized by use of the 3′ acceptor splice site …
- 229920001880 Circular RNA 0 title abstract description 223
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Greco et al. | Circular RNAs in muscle function and disease | |
Zhao et al. | Circular RNAs: biogenesis, mechanism, and function in human cancers | |
Ala | Competing endogenous RNAs, non-coding RNAs and diseases: an intertwined story | |
Chan et al. | Noncoding RNA: RNA regulatory networks in cancer | |
Xu et al. | New insights into the interplay between non-coding RNAs and RNA-binding protein HnRNPK in regulating cellular functions | |
Martinez-Sanchez et al. | MicroRNA target identification—experimental approaches | |
Thibault et al. | hnRNP A/B proteins: an encyclopedic assessment of their roles in homeostasis and disease | |
Fochi et al. | The emerging role of the RBM20 and PTBP1 ribonucleoproteins in heart development and cardiovascular diseases | |
Jakobi et al. | Deep characterization of circular RNAs from human cardiovascular cell models and cardiac tissue | |
Zhang et al. | MicroRNA-27b-3p targets the myostatin gene to regulate myoblast proliferation and is involved in myoblast differentiation | |
Sheu et al. | Gene expression changes associated with nintedanib treatment in idiopathic pulmonary fibrosis fibroblasts: a next-generation sequencing and bioinformatics study | |
Lassmann et al. | Telomerase reverse transcriptase regulates microRNAs | |
Elnour et al. | Circular RNA circMYL1 inhibit proliferation and promote differentiation of myoblasts by sponging miR-2400 | |
Wang et al. | miR-198 represses the proliferation of HaCaT cells by targeting cyclin D2 | |
Woo et al. | The interaction between 30b-5p miRNA and MBNL1 mRNA is involved in vascular smooth muscle cell differentiation in patients with coronary atherosclerosis | |
Stelcer et al. | The role of microRNAs in early chondrogenesis of human induced pluripotent stem cells (hiPSCs) | |
Gasparini et al. | The secret garden of neuronal circRNAs | |
Gandhi et al. | Evolutionary patterns of non-coding RNA in cardiovascular biology | |
Lyu et al. | Chi-miR-487b-3p inhibits goat myoblast proliferation and differentiation by targeting IRS1 through the IRS1/PI3K/Akt signaling pathway | |
Zhou et al. | Role of circular RNAs in pulmonary fibrosis | |
Faravelli et al. | The SMN complex at the crossroad between RNA metabolism and neurodegeneration | |
Hu et al. | miR-143 targeting CUX1 to regulate proliferation of dermal papilla cells in Hu sheep | |
Wang et al. | miR-100-5p regulates skeletal muscle myogenesis through the Trib2/mTOR/S6K signaling pathway | |
Pellegrino et al. | LINC00152 drives a competing endogenous RNA network in human hepatocellular carcinoma | |
Kim et al. | Competing endogenous RNA of snail and Zeb1 UTR in therapeutic resistance of colorectal cancer |